PortfoliosLab logo

Defiance Nasdaq Junior Biotechnology ETF (IBBJ)

ETF · Currency in USD
ISIN
US26922A1491
CUSIP
26922A149
Issuer
Defiance ETFs
Inception Date
Aug 3, 2020
Region
North America (U.S.)
Category
Health & Biotech Equities
Expense Ratio
0.45%
Index Tracked
NASDAQ Junior Biotechnology Index
ETF Home Page
www.defianceetfs.com
Asset Class
Equity

Asset Class Size

Multi-Cap

Asset Class Style

Growth

IBBJPrice Chart


Chart placeholderClick Calculate to get results

IBBJPerformance

The chart shows the growth of $10,000 invested in Defiance Nasdaq Junior Biotechnology ETF on Aug 5, 2020 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $12,133 for a total return of roughly 21.33%. All prices are adjusted for splits and dividends.


IBBJ (Defiance Nasdaq Junior Biotechnology ETF)
Benchmark (S&P 500)

IBBJReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-1.31%-0.73%
6M-6.28%10.61%
YTD-13.27%24.26%
1Y-9.06%26.07%
5Y15.36%29.01%
10Y15.36%29.01%

IBBJMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

IBBJSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Defiance Nasdaq Junior Biotechnology ETF Sharpe ratio is -0.26. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


IBBJ (Defiance Nasdaq Junior Biotechnology ETF)
Benchmark (S&P 500)

IBBJDividends

Defiance Nasdaq Junior Biotechnology ETF granted a 0.00% dividend yield in the last twelve months, as of Dec 26, 2021. The annual payout for that period amounted to $0.30 per share.


PeriodTTM2020
Dividend$0.30$0.30

Dividend yield

0.00%0.87%

IBBJDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


IBBJ (Defiance Nasdaq Junior Biotechnology ETF)
Benchmark (S&P 500)

IBBJWorst Drawdowns

The table below shows the maximum drawdowns of the Defiance Nasdaq Junior Biotechnology ETF. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Defiance Nasdaq Junior Biotechnology ETF is 31.81%, recorded on Oct 6, 2021. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-31.81%Feb 9, 2021167Oct 6, 2021
-6.68%Sep 1, 20205Sep 8, 20204Sep 14, 20209
-6.64%Dec 24, 20206Jan 4, 20218Jan 14, 202114
-6.52%Sep 21, 20204Sep 24, 20207Oct 5, 202011
-5.87%Jan 20, 20218Jan 29, 20213Feb 3, 202111
-5.36%Oct 14, 202013Oct 30, 20203Nov 4, 202016
-2.98%Aug 20, 20206Aug 27, 20202Aug 31, 20208
-2.72%Aug 11, 20201Aug 11, 20204Aug 17, 20205
-2.29%Nov 6, 20201Nov 6, 20203Nov 11, 20204
-1.64%Nov 18, 20201Nov 18, 20206Nov 27, 20207

IBBJVolatility Chart

Current Defiance Nasdaq Junior Biotechnology ETF volatility is 0.83%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


IBBJ (Defiance Nasdaq Junior Biotechnology ETF)
Benchmark (S&P 500)

Portfolios with Defiance Nasdaq Junior Biotechnology ETF


Loading data...

More Tools for Defiance Nasdaq Junior Biotechnology ETF